BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34680485)

  • 1. Transcriptional Profiling of Tumorspheres Reveals TRPM4 as a Novel Stemness Regulator in Breast Cancer.
    Verigos J; Kordias D; Papadaki S; Magklara A
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells.
    Hermawan A; Putri H; Fatimah N; Prasetio HH
    Heliyon; 2024 Jan; 10(2):e24356. PubMed ID: 38304813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
    Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
    Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
    Wong KK; Hussain FA
    PLoS One; 2020; 15(6):e0233884. PubMed ID: 32484822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial acquisition of stemness properties in tumorspheres obtained from interleukin-8-treated MCF-7 cells.
    Ospina-Muñoz N; Vernot JP
    Tumour Biol; 2020 Dec; 42(12):1010428320979438. PubMed ID: 33325322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Long Non-Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis.
    Qin Y; Hou Y; Liu S; Zhu P; Wan X; Zhao M; Peng M; Zeng H; Li Q; Jin T; Cui X; Liu M
    Adv Sci (Weinh); 2021 Jan; 8(2):2002232. PubMed ID: 33511005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.
    Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H
    Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2OT lncRNA Inhibition Suppresses the Stemness Characteristics of Esophageal Tumorspheres.
    Haghi B; Saghaeian Jazi M; Khosravi A; Jafari SM; Asadi J
    Noncoding RNA; 2022 Nov; 8(6):. PubMed ID: 36548179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.
    Chopra S; Goel S; Thakur B; Bhatia A
    Pathol Oncol Res; 2020 Jan; 26(1):371-378. PubMed ID: 30361903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
    Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
    Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
    J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of Gene Expression Associated with Stemness and Aggressiveness of ALDH1A1-Expressing Human Breast Cancer Cells.
    Wanandi SI; Syahrani RA; Arumsari S; Wideani G; Hardiany NS
    Malays J Med Sci; 2019 Sep; 26(5):38-52. PubMed ID: 31728117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
    Ginestier C; Monville F; Wicinski J; Cabaud O; Cervera N; Josselin E; Finetti P; Guille A; Larderet G; Viens P; Sebti S; Bertucci F; Birnbaum D; Charafe-Jauffret E
    Stem Cells; 2012 Jul; 30(7):1327-37. PubMed ID: 22605458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA profile revealed by microarray indicates that lncCUEDC1 serves a negative regulatory role in breast cancer stem cells.
    Zhang F; Ma Y; Xu L; Xu H; Xu Y; Yan N
    Int J Oncol; 2020 Mar; 56(3):807-820. PubMed ID: 32124947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance.
    Cajigas-Du Ross CK; Martinez SR; Woods-Burnham L; Durán AM; Roy S; Basu A; Ramirez JA; Ortiz-Hernández GL; Ríos-Colón L; Chirshev E; Sanchez-Hernandez ES; Soto U; Greco C; Boucheix C; Chen X; Unternaehrer J; Wang C; Casiano CA
    Oncotarget; 2018 Jul; 9(54):30363-30384. PubMed ID: 30100995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.